Tinea faciei may be subdivided into tinea barbae and fungal infection
at other facial sites, The correct diagnosis of tinea faciei should be
established and the causative organism(s) sought, Successful treatmen
t response is linked to concomitantly detecting and controlling the so
urce of infection, Oral therapy is more likely to be needed in tinea b
arbae than in tinea infection at other sites of the face, since topica
l medications do not adequately pentrate terminal hair follicles, Our
positive experience with terbinafine suggests that it may be an altern
ative therapy to griseofulvin and ketoconazole, which have been first-
line therapies for this condition.